company background image
SUNZEN logo

Sunzen Biotech Berhad KLSE:SUNZEN Stock Report

Last Price

RM0.32

Market Cap

RM225.7m

7D

1.6%

1Y

56.1%

Updated

27 Mar, 2024

Data

Company Financials

Sunzen Biotech Berhad

KLSE:SUNZEN Stock Report

Market Cap: RM225.7m

SUNZEN Stock Overview

Sunzen Biotech Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally.

SUNZEN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Sunzen Biotech Berhad Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sunzen Biotech Berhad
Historical stock prices
Current Share PriceRM0.32
52 Week HighRM0.34
52 Week LowRM0.19
Beta1.77
1 Month Change10.34%
3 Month Change8.47%
1 Year Change56.10%
3 Year Change52.38%
5 Year Change100.00%
Change since IPO71.43%

Recent News & Updates

Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Nov 16
What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Recent updates

Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Sunzen Biotech Berhad (KLSE:SUNZEN) Shareholders Will Want The ROCE Trajectory To Continue

What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Nov 16
What Sunzen Biotech Berhad's (KLSE:SUNZEN) 27% Share Price Gain Is Not Telling You

Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?

Mar 26
Health Check: How Prudently Does Sunzen Biotech Berhad (KLSE:SUNZEN) Use Debt?

Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?

Dec 10
Is Sunzen Biotech Berhad (KLSE:SUNZEN) Weighed On By Its Debt Load?

Shareholder Returns

SUNZENMY Personal ProductsMY Market
7D1.6%-0.4%0.5%
1Y56.1%8.3%11.4%

Return vs Industry: SUNZEN exceeded the MY Personal Products industry which returned 8.3% over the past year.

Return vs Market: SUNZEN exceeded the MY Market which returned 11.4% over the past year.

Price Volatility

Is SUNZEN's price volatile compared to industry and market?
SUNZEN volatility
SUNZEN Average Weekly Movement4.9%
Personal Products Industry Average Movement5.5%
Market Average Movement5.2%
10% most volatile stocks in MY Market11.8%
10% least volatile stocks in MY Market2.4%

Stable Share Price: SUNZEN has not had significant price volatility in the past 3 months.

Volatility Over Time: SUNZEN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998n/aYek Teohttps://www.sunzen.com.my

Sunzen Biotech Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other products; trades in crude palm oil and derivative products; and manufactures, imports, trades in, exports, and sells bird’s nests and related products.

Sunzen Biotech Berhad Fundamentals Summary

How do Sunzen Biotech Berhad's earnings and revenue compare to its market cap?
SUNZEN fundamental statistics
Market capRM225.70m
Earnings (TTM)RM6.82m
Revenue (TTM)RM98.13m

33.1x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SUNZEN income statement (TTM)
RevenueRM98.13m
Cost of RevenueRM67.55m
Gross ProfitRM30.58m
Other ExpensesRM23.76m
EarningsRM6.82m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.0097
Gross Margin31.16%
Net Profit Margin6.95%
Debt/Equity Ratio4.8%

How did SUNZEN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.